AAVsembly☰

Rare disease genes in AAV

Every gene we hold a coding length for, grouped by what the vector strategy has to be. Lengths are the MANE Select transcript from NCBI. These pages say what fits, not how much expression you will get.

One vector, comfortably 98

Room left over for a stronger promoter or a reporter.

ABCD1
2,238 bp
X-linked adrenoleukodystrophy
ACADM
1,266 bp
Medium-chain acyl-CoA dehydrogenase deficiency
ADA
1,092 bp
ADA-SCID
AGXT
1,179 bp
Primary hyperoxaluria type 1
ARSA
1,530 bp
Metachromatic leukodystrophy
ARSB
1,602 bp
Mucopolysaccharidosis type VI
ASL
1,395 bp
Argininosuccinic aciduria
ASPA
942 bp
Canavan disease
ASS1
1,239 bp
Citrullinemia type I
ATF6
2,013 bp
Achromatopsia
BBS1
1,782 bp
Bardet-Biedl syndrome
BBS10
2,172 bp
Bardet-Biedl syndrome
BBS2
2,166 bp
Bardet-Biedl syndrome
BEST1
1,758 bp
Hereditary retinal dystrophy, BEST1-related
CHM
1,962 bp
Choroideremia
CLN3
1,317 bp
CLN3 disease
CLN5
1,077 bp
CLN5 disease
CNGA3
2,085 bp
Achromatopsia
CNGB3
2,430 bp
Achromatopsia
CYBB
1,713 bp
Chronic granulomatous disease, X-linked
CYP21A2
1,488 bp
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
DDC
1,443 bp
Aromatic L-amino acid decarboxylase deficiency
DNAI1
2,100 bp
Primary ciliary dyskinesia
ELANE
804 bp
Congenital neutropenia, ELANE-related
F9
1,386 bp
Hemophilia B
FAH
1,260 bp
Hereditary tyrosinemia type I
FGFR3
2,421 bp
Achondroplasia
FMR1
1,899 bp
Fragile X syndrome
FOXP3
1,296 bp
IPEX syndrome
FXN
633 bp
Friedreich ataxia
G6PC1
1,074 bp
Glycogen storage disease type Ia
GALC
2,058 bp
Krabbe disease
GAN
1,794 bp
Giant axonal neuropathy
GBA1
1,611 bp
Gaucher disease
GJB1
852 bp
Charcot-Marie-Tooth disease type 1X
GJB2
681 bp
GJB2-related hearing loss
GLA
1,290 bp
Fabry disease
GLB1
2,034 bp
GM1 gangliosidosis
GNAT2
1,065 bp
Achromatopsia
HADHA
2,292 bp
Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency
HBB
444 bp
Sickle cell disease
HDAC8
1,134 bp
Cornelia de Lange syndrome
HEXA
1,590 bp
GM2 gangliosidosis Tay-Sachs
HEXB
1,671 bp
Sandhoff disease
IDS
1,653 bp
Mucopolysaccharidosis type II
IDUA
1,962 bp
Mucopolysaccharidosis type I
IFITM5
399 bp
Osteogenesis imperfecta
IL2RG
1,110 bp
X-linked severe combined immunodeficiency
LAMP2
1,233 bp
Danon disease
LDLR
2,583 bp
Familial hypercholesterolemia
LDLRAP1
927 bp
Familial hypercholesterolemia
LMNA
1,995 bp
Progeria, Hutchinson-Gilford
MECP2
1,497 bp
Rett syndrome
MFSD8
1,557 bp
CLN7 disease
MMUT
2,253 bp
Methylmalonic acidemia, mut type
MTM1
1,812 bp
X-linked myotubular myopathy
NAGLU
2,232 bp
Mucopolysaccharidosis type IIIB
NDUFS4
528 bp
Leigh syndrome
NF2
1,788 bp
Neurofibromatosis type 2-related schwannomatosis
NPC2
456 bp
Niemann-Pick disease type C2
OTC
1,065 bp
Ornithine transcarbamylase deficiency
PAH
1,359 bp
Phenylketonuria
PCCA
2,187 bp
Propionic acidemia
PCCB
1,620 bp
Propionic acidemia
PCSK9
2,079 bp
Familial hypercholesterolemia
PDE6C
2,577 bp
Achromatopsia
PDE6H
252 bp
Achromatopsia
PMP22
483 bp
Charcot-Marie-Tooth disease type 1A
PRF1
1,668 bp
Familial hemophagocytic lymphohistiocytosis type 2
PTPN11
1,782 bp
Noonan syndrome
RAD21
1,896 bp
Cornelia de Lange syndrome
RAF1
1,947 bp
Noonan syndrome
RB1
2,787 bp
Retinoblastoma
RIT1
660 bp
Noonan syndrome
RPE65
1,602 bp
Leber congenital amaurosis 2
RPL11
537 bp
Diamond-Blackfan anemia
RPL5
894 bp
Diamond-Blackfan anemia
RPS19
438 bp
Diamond-Blackfan anemia
SERPINA1
1,257 bp
Alpha-1 antitrypsin deficiency
SERPING1
1,503 bp
Hereditary angioedema type I/II
SGSH
1,509 bp
Mucopolysaccharidosis type IIIA
SH2D1A
387 bp
X-linked lymphoproliferative disease type 1
SLC37A4
1,290 bp
Glycogen storage disease type Ib
SMN1
885 bp
Spinal muscular atrophy
SMN2
885 bp
Spinal muscular atrophy
SOD1
465 bp
Amyotrophic lateral sclerosis, SOD1-related
SURF1
903 bp
Leigh syndrome
TAZ
879 bp
Barth syndrome
TCF4
2,016 bp
Pitt-Hopkins syndrome
TK2
798 bp
Mitochondrial DNA depletion syndrome, TK2-related
TP53
1,182 bp
Li-Fraumeni syndrome
TPP1
1,692 bp
CLN2 disease
TTR
444 bp
Hereditary transthyretin amyloidosis
UBE3A
2,619 bp
Angelman syndrome
UGT1A1
1,602 bp
Crigler-Najjar syndrome type I
VHL
642 bp
Von Hippel-Lindau disease
WAS
1,509 bp
Wiskott-Aldrich syndrome
XPA
822 bp
Xeroderma pigmentosum group A

One vector, tight 15

Fits, but the promoter choice starts to matter.

Two vectors 22

Split the protein and rejoin it with a split intein, as the marketed dual-AAV OTOF therapy does.

Three vectors 9

Two orthogonal inteins, and less efficient than a pair.

No AAV route we would recommend 7

Too large for anything we would build. A shortened protein or a different modality is the honest answer.